125 related articles for article (PubMed ID: 31020761)
1. Synthetic microRNA-205 exhibited tumour suppression in spontaneous canine malignant melanoma by intratumoral injection.
Yoshikawa R; Mori T; Noguchi S; Akao Y; Maruo K; Kitade Y
Vet Comp Oncol; 2019 Sep; 17(3):407-412. PubMed ID: 31020761
[TBL] [Abstract][Full Text] [Related]
2. Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo.
Noguchi S; Iwasaki J; Kumazaki M; Mori T; Maruo K; Sakai H; Yamada N; Shimada K; Naoe T; Kitade Y; Akao Y
Mol Ther; 2013 Jun; 21(6):1204-11. PubMed ID: 23629002
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas.
Noguchi S; Mori T; Hoshino Y; Yamada N; Maruo K; Akao Y
Vet Comp Oncol; 2013 Jun; 11(2):113-23. PubMed ID: 23638671
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma.
Noguchi S; Mori T; Hoshino Y; Yamada N; Nakagawa T; Sasaki N; Akao Y; Maruo K
J Vet Med Sci; 2012 Jan; 74(1):1-8. PubMed ID: 21836381
[TBL] [Abstract][Full Text] [Related]
5. In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
Dow SW; Elmslie RE; Willson AP; Roche L; Gorman C; Potter TA
J Clin Invest; 1998 Jun; 101(11):2406-14. PubMed ID: 9616212
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic applications of local injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors.
Yoshikawa R; Inoue J; Iwasaki R; Terauchi M; Fujii Y; Ohta M; Hasegawa T; Mizuno R; Mori T; Inazawa J
Cancer Gene Ther; 2023 Nov; 30(11):1524-1529. PubMed ID: 37553484
[TBL] [Abstract][Full Text] [Related]
7. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma.
von Euler H; Sadeghi A; Carlsson B; Rivera P; Loskog A; Segall T; Korsgren O; Tötterman TH
J Immunother; 2008 May; 31(4):377-84. PubMed ID: 18391758
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.
Hwang CC; Igase M; Sakurai M; Haraguchi T; Tani K; Itamoto K; Shimokawa T; Nakaichi M; Nemoto Y; Noguchi S; Coffey M; Okuda M; Mizuno T
Vet Comp Oncol; 2018 Jun; 16(2):229-238. PubMed ID: 29076241
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.
Noguchi S; Mori T; Nakagawa T; Itamoto K; Haraguchi T; Mizuno T
Melanoma Res; 2015 Oct; 25(5):390-8. PubMed ID: 26225581
[TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated microRNA expression in canine uveal melanoma.
Starkey MP; Compston-Garnett L; Malho P; Dunn K; Dubielzig R
Vet Comp Oncol; 2018 Mar; 16(1):81-89. PubMed ID: 28512868
[TBL] [Abstract][Full Text] [Related]
11. Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.
Noguchi S; Kumazaki M; Mori T; Baba K; Okuda M; Mizuno T; Akao Y
Vet Comp Oncol; 2016 Dec; 14(4):384-394. PubMed ID: 25280339
[TBL] [Abstract][Full Text] [Related]
12. The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo.
Ito K; Kobayashi M; Kuroki S; Sasaki Y; Iwata T; Mori K; Kuroki T; Ozawa Y; Tetsuka M; Nakagawa T; Hiroi T; Yamamoto H; Ono K; Washizu T; Bonkobara M
Vet J; 2013 Dec; 198(3):577-82. PubMed ID: 24035468
[TBL] [Abstract][Full Text] [Related]
13. Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats.
LeBlanc AK; Atherton M; Bentley RT; Boudreau CE; Burton JH; Curran KM; Dow S; Giuffrida MA; Kellihan HB; Mason NJ; Oblak M; Selmic LE; Selting KA; Singh A; Tjostheim S; Vail DM; Weishaar KM; Berger EP; Rossmeisl JH; Mazcko C
Vet Comp Oncol; 2021 Jun; 19(2):311-352. PubMed ID: 33427378
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow-up.
Finocchiaro LM; Glikin GC
Cancer Gene Ther; 2012 Dec; 19(12):852-61. PubMed ID: 23059870
[TBL] [Abstract][Full Text] [Related]
15. Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.
Nguyen SM; Thamm DH; Vail DM; London CA
Vet Comp Oncol; 2015 Sep; 13(3):176-83. PubMed ID: 23534501
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
[TBL] [Abstract][Full Text] [Related]
18. Enhancing antimelanoma immune responses through apoptosis.
Bianco SR; Sun J; Fosmire SP; Hance K; Padilla ML; Ritt MG; Getzy DM; Duke RC; Withrow SJ; Lana S; Matthiesen DT; Dow SW; Bellgrau D; Cutter GR; Helfand SC; Modiano JF
Cancer Gene Ther; 2003 Sep; 10(9):726-36. PubMed ID: 12944992
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M
Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen.
Gyorffy S; Rodriguez-Lecompte JC; Woods JP; Foley R; Kruth S; Liaw PC; Gauldie J
J Vet Intern Med; 2005; 19(1):56-63. PubMed ID: 15715049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
